[Protective effects of hemochromatosis against senile and diabetic angiopathies].
D000367:Age Factors; D000368:Aged; D000375:Aging; D001161:Arteriosclerosis / Q000503:physiopathology*; D001344:Autopsy; D001835:Body Weight; D002784:Cholesterol / Q000097:blood; D003327:Coronary Disease / Q000503:physiopathology; D003920:Diabetes Mellitus / Q000503:physiopathology; D003925:Diabetic Angiopathies / Q000503:physiopathology*; D003928:Diabetic Nephropathies / Q000503:physiopathology; D003930:Diabetic Retinopathy / Q000209:etiology / Q000503:physiopathology; D005260:Female; D005951:Glucose Tolerance Test; D006432:Hemochromatosis / Q000503:physiopathology*; D006801:Humans; D007668:Kidney / Q000098:blood supply; D008103:Liver Cirrhosis / Q000378:metabolism / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D012171:Retinal Vessels; D012737:Sex Factors
D002784:Cholesterol
Effet protecteur de l'hemochromatose vis-à-vis des lésions vasculaires séniles ou diabétiques.